0000950123-23-002219.txt : 20230214 0000950123-23-002219.hdr.sgml : 20230214 20230214074645 ACCESSION NUMBER: 0000950123-23-002219 CONFORMED SUBMISSION TYPE: 13F-NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230214 DATE AS OF CHANGE: 20230214 EFFECTIVENESS DATE: 20230214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BC SW, LP CENTRAL INDEX KEY: 0001786351 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-NT SEC ACT: 1934 Act SEC FILE NUMBER: 028-20270 FILM NUMBER: 23622559 BUSINESS ADDRESS: STREET 1: 200 CLAREDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6175162000 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-NT 1 primary_doc.xml X0202 13F-NT LIVE 0001786351 XXXXXXXX 12-31-2022 12-31-2022 false BC SW, LP

200 Clarendon Street Boston MA 02116

13F NOTICE 028-20270 28-18477 Bain Capital Life Sciences Investors, LLC Y The report on Form 13F for the period ended December 31, 2022 for BC SW, LP ("BC SW") is being filed by Bain Capital Life Sciences Investors, LLC, which is the general partner of BC SW. Adam Koppel 617-516-2000 /s/ Adam Koppel Boston MA 02-14-2023